Found 5 matching trials
Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)
PHASE1This example study is an open-label, multi-center, adaptive Phase 1/2 trial...
Location
Peking University Shenzhen Hospital
Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer
PHASE2This is an open-label umbrella study conducted in first treatment ES-SCLC p...
Location
Tianjin Medical University Cancer Institute and Hospital, Tianjin, China 300060
Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)
PHASE1This study is an open-label, multi-center, adaptive Phase 1/2 trial evaluat...
Location
Peking University Shenzhen Hospital
Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung Cancer
PHASE1This is a multicenter, open-label, phase I clinical trial aimed to evaluate...
Location
Tianjin Medical University Cancer Institute and Hospital
Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients
PHASE1This is a Phase I clinical trial being conducted in humans for the first ti...
Location
Cancer Hospital of CICAMS